Beruflich Dokumente
Kultur Dokumente
Key Words were a strong predictor of poor QoL in OCD patients. Con-
Obsessive-compulsive disorder, subtypes and clusions: In order to judge the QoL of OCD patients, obses-
heterogeneity Subjective quality of life WHOQOL-BREF sions and compulsions have to be considered differently. Di-
agnosing and treating depressive symptoms is important
for improving the QoL in OCD. Copyright © 2007 S. Karger AG, Basel
Abstract
Background: Patients with obsessive-compulsive disorder
(OCD) are troubled by repeated obsessions and/or compul-
sions, which seem senseless and frequently repugnant. Ob- Introduction
jective: The study examines the differential impact of obses-
sions and compulsions on the quality of life (QoL) of patients There is growing evidence suggesting that anxiety
with OCD. Methods: Seventy-five patients (43 females, 32 and affective disorders may be associated with substan-
males) between 21 and 62 years old with OCD (ICD 10 F42.0– tial impairments in quality of life (QoL) [1–3]. In addi-
F42.2) were recruited from the outpatient clinic for anxiety tion, it is generally accepted that obsessive-compulsive
disorders at the Department of Psychiatry of the University disorder (OCD) is a chronic and severely disabling dis-
of Leipzig. The severity of OCD symptoms was assessed by order ranking tenth in the World Bank’s and WHO’s
the Yale Brown Obsessive-Compulsive Scale (a standardized, leading causes of disability [4]. OCD impacts everyday
clinician-administered scale), and depressiveness was as- life in academic, occupational, social, and family func-
sessed with the Beck Depression Inventory (a self-report in- tioning [2–5]. Therefore, it is not surprising that QoL in
strument). QoL was assessed by means of the WHOQOL- OCD is lower than in the general population [3, 6, 8]. In
BREF, a self-administered questionnaire developed by contrast, studies comparing OCD patients to other men-
WHO. Results: Compulsions reduced patients’ QoL in the tal disorder samples have yielded inconsistent results [2,
WHOQOL-BREF domains ‘physical well-being’, ‘psychologi- 7–9]. These inconsistent results may come from differ-
cal well-being’ and ‘environment’, whereas obsessions did ences among the study designs, including very different
not have any impact on QoL ratings. Depressive symptoms QoL instruments and the criteria of inclusion and exclu-
198.143.37.97 - 1/27/2016 9:50:08 AM
George Washington Univ. Med.Ct
www.karger.com www.karger.com/psp Tel. +49 341 972 4501, Fax +49 341 972 4509, E-Mail stenglk@medizin.uni-leipzig.de
sion of the samples, especially inclusion of comorbid de- an important outcome measure in patients with mental
pressive symptoms. illnesses [19, 20].
Another important area of research in QoL and OCD While this definition describes the different dimen-
explores the association between QoL and clinical out- sions of the QoL concept, most of the previously devel-
come. In psychiatry in general QoL may be considered an oped instruments measuring health-related QoL deviate
outcome criterion for the therapeutic process. It is impor- from each other sharply in the interpretation and weigh-
tant for the therapist to find the subjective perspective of ing of single dimensions [21]. Many of the previously
patients as he measures functional impairment from ill- used QoL instruments concentrated on capturing func-
ness and potential side effects from treatment. Such in- tional impairment resulting from illness symptoms, like
sight helps the therapist create a basis to construct an ad- the Medical Outcome Study Approach (MOS-SF 36) [17],
equate treatment strategy for the patient. Some studies the Sickness Impact Profile [22] or the Illness Intrusive-
reported that QoL improves over the course of psycho- ness Rating Scale [15]. Other instruments have focused
therapy and psychopharmacological treatment in OCD on impairment of the level of social functioning, like the
[9–13]. However, there is some evidence that QoL in- Global Assessment of Functioning Scale [23], the Shee-
creases independent of symptom improvement. Whereas han Disability Inventory [24] or the Liebowitz Self-Rat-
Tenney et al. [12] found responders and nonresponders ing Disability Scale [25]. Further qualifications in com-
showing equal improvement in QoL in OCD, Moritz et parability result from the fact that many instruments
al. [13] reported that QoL improvement was larger in were developed either solely for the areas of somatic clin-
those responding to treatment than in those not respond- ical data [26, 27], or they can only be employed for cap-
ing. Yet the methodical differences of these few studies turing QoL in mental illnesses, like the Lehman Quality
permit no generalizations to date on the results. of Life Interview [28] or the Lancashire Quality of Life
While the severity of OCD is weakly correlated with Profile [29]. In addition to these conceptual differences,
QoL, only a few studies have assessed the correlation of substantial problems also result when making interna-
QoL and subtypes of OCD, especially different symptoms tional and intercultural comparisons of results gathered
including depressiveness. For instance, Masellis et al. [14] through translations of individual instruments [26, 30].
examined the differing impact of obsessions, compul- In recent years researchers have tried to allow for these
sions and comorbid depression on the QoL in OCD pa- methodical limitations of various QoL instruments by
tients. This study from Canada using the Illness Intru- beginning various international projects to develop QoL
siveness Rating Scale [15] showed that QoL, measured as instruments, such as the International Life Assessment
illness intrusiveness, was especially affected by obses- Project [31] or the World Health Organization Quality of
sions, but not by compulsions. These findings are sup- Life Group (WHOQOL Group) [18]. In the context of this
ported by a study identifying the presence of obsessions development of the QoL instruments and the correspond-
of sexual/religious and aggressive content as a unique fac- ing limitations of individual instruments, using the
tor related to a poorer long-term clinical outcome in OCD WHOQOL-BREF as an internationally recognized in-
[16]. Masellis et al. [14] also reported that comorbid de- strument was a corollary of this study.
pression severity was the single greatest predictor of The aim of this study was to examine whether the
poorer QoL. This agrees with a study by Moritz et al. [13], findings obtained by Masellis et al. [14] can be replicated
who found correlations between QoL, depression sever- using another instrument for the assessment of QoL. A
ity and a number of OCD symptoms. Using the SF-36 summary of the literature on QoL and OCD strongly sug-
(MOS-SF 36) [17], these authors reported that the sever- gested using the WHOQOL-BREF for the present study
ity and number of obsessions were most strongly related as a new international QoL instrument that is consid-
to the role-emotional and mental health subscales of the ered a valid and reliable measure for assessing QoL pro-
QoL, whereas the number of compulsions showed a rath- files in different populations, including patient samples
er even pattern of correlation with the QoL subscales. (WHOQOL Group) [18]. In addition, we were interested
According to the WHO, health-related subjective QoL in knowing which domains of QoL were particularly af-
is conceptualized as a generic, multidimensional con- fected by obsessions and compulsions. And last but not
struct that describes an individual’s subjective perception least, in view of the consistent results of both Masellis et
of their own physical health, social functioning, environ- al. [14] and Moritz et al. [13], we expected depressive
ment, and general life quality [18]. Especially in recent symptoms to be most strongly associated with QoL.
years this QoL concept has been increasingly accepted as
198.143.37.97 - 1/27/2016 9:50:08 AM
George Washington Univ. Med.Ct
Gender (female) 2.90 3.23 0.374 2.46 3.26 0.455 5.52 6.39 0.392 5.81 3.31 0.086
Age –0.31 0.17 0.071 0.11 0.17 0.506 0.58 0.33 0.088 –0.31 0.17 0.081
Education1
School leaving examination
(‘Mittlere Reife’) 5.27 5.64 0.355 –5.12 5.71 0.373 9.05 11.17 0.422 –7.5 5.79 0.204
Completed polytechnic
(‘Fachhochschule’) 1.57 6.48 0.809 –6.48 6.55 0.327 –13.04 12.82 0.314 –0.46 6.65 0.945
Completed college –2.14 5.82 0.714 8.38 5.89 0.161 –0.69 11.52 0.952 10.33 5.98 0.090
University graduate 0.63 5.01 0.900 –6.73 5.07 0.190 1.83 9.92 0.854 –1.85 5.14 0.720
Completed postgraduate degree 9.19 8.49 0.285 –5.77 8.59 0.505 –0.95 16.81 0.955 –5.64 8.72 0.520
Occupational status2 (employed) –1.40 3.56 0.695 –4.53 3.60 0.214 –5.72 7.05 0.421 –5.69 3.66 0.126
Duration of illness, years –0.03 0.18 0.852 –0.09 0.18 0.624 –0.27 0.35 0.440 0.30 0.18 0.101
Y-BOCS subscores
Obsession –0.33 0.33 0.322 0.12 0.34 0.712 0.54 0.66 0.422 0.33 0.34 0.340
Compulsion –1.37 0.36 0.000 –0.98 0.37 0.010 –0.49 0.72 0.501 –1.43 0.37 0.000
BDI (total score) –0.96 0.16 0.000 –1.53 0.17 0.000 –0.68 0.33 0.044 –0.37 0.17 0.035
Constant 104.82 9.26 0.000 84.92 9.36 0.000 42.31 18.32 0.025 95.00 9.50 0.000
F(12.49) = 8.25; F(12.49) = 10.21; F(12.49) = 1.06; F(12.49) = 2.45;
p = 0.000 p = 0.000 p = 0.413 p = 0.014
R2adj.= 0.588 R2adj.= 0.644 R2adj.= 0.012 R2adj.= 0.222
1 Reference category = high school not completed.
2 Reference category = unemployed.
1 Kuehner C, Buerger C: Determinants of sub- 14 Masellis M, Rector NA, Richter MA: Quality 28 Lehman AF: The well-being of chronic men-
jective quality of life in depressed patients: of life in OCD: differential impact of obses- tal patients: assessing their quality of life.
the role of self-esteem, response styles, and sions, compulsions, and depression co-mor- Arch Gen Psychiatry 1983;40:369–373.
social support. J Affect Disord 2005;86:205– bidity. Can J Psychiatry 2003;48:72–77. 29 Oliver JP, Huxley PJ, Priebe S, Kaiser W:
213. 15 Devins GM: Illness intrusiveness and the Measuring the quality of life of severely men-
2 Lochner C, Mogotsi M, du Toit PL, Kaminer psychosocial impact of lifestyle disruptions tally ill people using the Lancashire Quality
D, Niehaus DJ, Stein DJ: Quality of life in in chronic life-threatening disease. Adv Ren of Life Profile. Soc Psychiatry Psychiatr Epi-
anxiety disorders: a comparison of obses- Replace Ther 1994;1:251–263. demiol 1997;32:76–83.
sive-compulsive disorder, social anxiety dis- 16 Alonso P, Menchon JM, Pifarre J, Mataix- 30 Sartorius N, Janca A: Psychiatric assessment
order, and panic disorder. Psychopathology Cols D, Torres L, Salgado P, Vallejo J: Long- instruments developed by the World Health
2003;35:255–262. term follow-up and predictors of clinical Organization. Soc Psychiatry Psychiatr Epi-
3 Rapaport MH, Clary C, Fayyad R, Endicott outcome in obsessive-compulsive patients demiol 1996;31:55–69.
J: Quality-of-life impairment in depressive treated with serotonin reuptake inhibitors 31 Aaronson NK, Acquadro C, Alonso J, Apo-
and anxiety disorders. Am J Psychiatry 2005; and behavioral therapy. J Clin Psychiatry lone G, Bucquet D, Bullinger M, Bungay K,
162:1171–1178. 2001;62:535–540. Fukuhara S, Gandek B, Keller S: Internation-
4 Lopez AD, Murray CC: The global burden of 17 Ware JE, Sherbourne CD: The MOS 36-Item al Quality of Life Assessment (IQOLA) Proj-
disease, 1990–2020. Nat Med 1998; 4: 1241– Short-Form Health Survey (SF-36). I. Con- ect. Qual Life Res 1992;1:349–351.
1243. ceptual framework and item selection. Med 32 World Health Organization: The 10th revi-
5 Steketee G: Disability and family burden in Care 1992;30:473–483. sion of the International Classification of
obsessive-compulsive disorder. Can J Psy- 18 THE WHOQOL GROUP: Development of Diseases. Chapter V (F): Mental and Behav-
chiatry 1997;42:919–928. the World Health Organization WHOQOL- ioral Disorders. Göttingen, Huber, 1993.
6 Koran LM, Thienemann ML, Davenport R: BREF quality of life assessment. Soc Sci Med 33 Angermeyer MC, Kilian R, Matschinger H:
Quality of life for patients with obsessive- 1998;28:551–558. WHOQOL-100 und WHOQOL-BREF. Göt-
compulsive disorder. Am J Psychiatry 1996; 19 Priebe S: Research in quality of life in mental tingen, Hogrefe, 2000.
153:783–788. health care: aims and strategies; in Priebe S, 34 Goodman WK, Price LH, Rasmussen SA,
7 Hollander E, Kwon JH, Stein DJ, Broatch J, Oliver JPJ, Kaiser W (eds): Quality of Life Mazure C, Fleischmann RL, Hill CL, He-
Rowland CT, Himelein CA: Obsessive-com- and Mental Health Care. Petersfield, Wright- ninger GR, Charney DS: The Yale-Brown
pulsive and spectrum disorders: overview son Biomedical, 1999. Obsessive Compulsive Scale. I. Develop-
and quality of life issues. J Clin Psychiatry 20 Katschnig H: How useful is the concept of ment, use, and reliability. Arch Gen Psychia-
1996;57:3–6. quality of life in psychiatry; in Katschnig H, try 1989;46:1006–1011.
8 Bobes J, Gonzalez MP, Bascaran MT, Arango Freeman H, Sartorius N (eds): Quality of Life 35 Goodman WK, Price LH, Rasmussen SA,
C, Saiz PA, Bousono M: Quality of life and in Mental Disorders, ed 2. Chichester, Wiley, Mazure C, Delgado P, Heninger GR, Char-
disability in patients with obsessive-com- 2006. ney DS: The Yale-Brown Obsessive Compul-
pulsive disorder. Eur Psychiatry 2003; 16: 21 Nieuwenhuizen C: Instruments for mea- sive Scale. II. Validity. Arch Gen Psychiatry
239–245. suring quality of life in mental disorders. 1989;46:1012–1016.
9 Bystritsky A, Liberman RP, Hwang S, Wal- II. Some new developments; in Katschnig H, 36 Beck AT, Ward CH, Mendelson J, Mock J, Er-
lace CJ, Vapnik T, Maindment K, Saxena S: Freeman H, Sartorius N (eds): Quality of Life baugh J: An inventory for measuring depres-
Social functioning and quality of life com- in Mental Disorders, ed 2. Chichester, Wiley, sion. Arch Gen Psychiatry 1961;4:564–571.
parisons between obsessive-compulsive and 2006. 37 Stata Statistical Software (Computer Soft-
schizophrenic disorders. Depress Anxiety 22 Bergner M, Bobbitt RA, Carter WB, Gilson ware). College Station, Stata Corporation,
2001;14:214–218. BS: The sickness impact profile: develop- 2003.
10 Bystritsky A, Saxena S, Maidment K, Vapnik ment and final revision of a health status 38 Deacon BJ, Abramowitz JS: The Yale-Brown
T, Tarlow G, Rosen R: Quality-of-life chang- measure. Med Care 1981;19:787–805. Obsessive Compulsive Scale: factor analysis,
es among patients with obsessive-compul- 23 Endicott J, Spitzer RL, Fleiss JL, Cohen J: The construct validity, and suggestions for re-
sive disorder in a partial hospitalization pro- Global Assessment Scale: A Procedure for finement. J Anxiety Disord 2005; 19: 573–
gram. Psychiatr Serv 1999;50:412–414. Measuring Overall Severity of Psychiatric 585.
11 Volpato Cordioli A, Heldt E, Braga Bochi D, Disturbance. Arch Gen Psychiatry 1976; 33: 39 Monti M, Sambvani N, Sacrini F: Obsessive-
Margis R, Basso de Sousa M, Fonseca Tonel- 766–771. compulsive disorders in dermatology. J Eur
lo J, Gus Manfro G, Kapczinski F: Cognitive- 24 Sheehan DV: The Anxiety Disease. New Acad Dermatol Venereol 1998; 11:103–108.
behavioral group therapy in obsessive-com- York, Scribner, 1983. 40 Fineberg NA, O’Doherty C, Rajagopal S,
pulsive disorder: a randomized clinical trial. 25 Schneier FR, Heckelman LR, Garfinkel R, Reddy K, Banks A, Gale TM: How common
Psychother Psychosom 2003; 72:211–216. Campeas R, Fallon BA, Gitow A, Street L, Del is obsessive-compulsive disorder in a derma-
12 Tenney NH, Denys DA, van Megen HJ, Glas Bene D, Liebowitz MR: Functional impair- tology outpatient clinic? J Clin Psychiatry
G, Westenberg HG: Effect of a pharmacolog- ment in social phobia. J Clin Psychiatry 2003;64:152–155.
ical intervention on quality of life in patients 1994;55:322–331. 41 Frost RO, Steketee G, Williams LF, Warren
with obsessive-compulsive disorder. Int Clin 26 Aaronson NK, da Silva FC: Prospects for the R: Mood, personality disorder symptoms
Psychopharmacol 2003;18:29–33. future: quality of life evaluation in prostatic and disability in obsessive compulsive
13 Moritz S, Rufer M, Fricke S, Karow A, Mor- cancer protocols. Prog Clin Biol Res 1987; hoarders: a comparison with clinical and
feld M, Jelinek L, Jacobsen D: Quality of life 243:501–512. nonclinical controls. Behav Res Ther 2000;
in obsessive-compulsive disorder before and 27 Bullinger M, Hasford J: Evaluating quality- 38:1071–1081.
after treatment. Compr Psychiatry 2005;46: of-life measures for clinical trials in Germa- 42 Lochner C, Stein DJ: Heterogeneity of obses-
453–459. ny. Control Clin Trials 1991; 12:91–105. sive-compulsive disorder: a literature re-
view. Harv Rev Psychiatry 2003;11:113–132.
198.143.37.97 - 1/27/2016 9:50:08 AM
George Washington Univ. Med.Ct